IMAX ($IMAX) posted quarterly earnings results on Thursday, July 24th. The company reported earnings of $0.26 per share, beating estimates of $0.22 by $0.04. The company also reported revenue of $91,680,000, missing estimates of $93,047,460 by $-1,367,460.
You can see Quiver Quantitative's $IMAX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
IMAX Insider Trading Activity
IMAX insiders have traded $IMAX stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $IMAX stock by insiders over the last 6 months:
- RICHARD L GELFOND (Chief Executive Officer) sold 100,000 shares for an estimated $2,711,440
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
IMAX Hedge Fund Activity
We have seen 94 institutional investors add shares of IMAX stock to their portfolio, and 93 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANE STREET GROUP, LLC added 573,919 shares (+inf%) to their portfolio in Q1 2025, for an estimated $15,122,765
- PRICE T ROWE ASSOCIATES INC /MD/ added 501,453 shares (+2974.0%) to their portfolio in Q1 2025, for an estimated $13,213,286
- FMR LLC added 483,240 shares (+10.7%) to their portfolio in Q1 2025, for an estimated $12,733,374
- ORBIS ALLAN GRAY LTD added 425,081 shares (+12.3%) to their portfolio in Q1 2025, for an estimated $11,200,884
- DRIEHAUS CAPITAL MANAGEMENT LLC added 424,338 shares (+inf%) to their portfolio in Q1 2025, for an estimated $11,181,306
- JUPITER ASSET MANAGEMENT LTD added 417,677 shares (+805.9%) to their portfolio in Q1 2025, for an estimated $11,005,788
- GOLDMAN SACHS GROUP INC removed 367,984 shares (-53.7%) from their portfolio in Q1 2025, for an estimated $9,696,378
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
IMAX Analyst Ratings
Wall Street analysts have issued reports on $IMAX in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Rosenblatt issued a "Buy" rating on 07/11/2025
- Roth Capital issued a "Buy" rating on 07/09/2025
- Macquarie issued a "Outperform" rating on 04/25/2025
- Barrington Research issued a "Outperform" rating on 04/24/2025
- Wells Fargo issued a "Overweight" rating on 04/24/2025
- Benchmark issued a "Buy" rating on 04/10/2025
- Wedbush issued a "Outperform" rating on 02/12/2025
To track analyst ratings and price targets for IMAX, check out Quiver Quantitative's $IMAX forecast page.
IMAX Price Targets
Multiple analysts have issued price targets for $IMAX recently. We have seen 8 analysts offer price targets for $IMAX in the last 6 months, with a median target of $32.0.
Here are some recent targets:
- Steve Frankel from Rosenblatt set a target price of $35.0 on 07/11/2025
- Eric Handler from Roth Capital set a target price of $36.0 on 07/09/2025
- Chad Beynon from Macquarie set a target price of $32.0 on 04/25/2025
- Patrick Sholl from Barrington Research set a target price of $32.0 on 04/24/2025
- Omar Mejias from Wells Fargo set a target price of $30.0 on 04/24/2025
- David Karnovsky from JP Morgan set a target price of $26.0 on 04/11/2025
- Mike Hickey from Benchmark set a target price of $30.0 on 04/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
